Literature DB >> 17144905

Tau exon 6 is regulated by an intricate interplay of trans factors and cis elements, including multiple branch points.

Junning Wang1, Sze-Wah Tse, Athena Andreadis.   

Abstract

Tau is a microtubule-associated protein whose transcript undergoes complex regulated splicing in the mammalian nervous system. Exon 6 of the gene is an alternatively spliced cassette whose expression profile differs from that of the other tau regulated exons, implying the involvement of distinct regulatory factors. Previous work had established the existence and use of two additional 3' splice sites within exon 6 and the influence of splicing factors polypyrimidine binding protein (PTB) and U2AF on its splicing. The present work shows that exon 6 isoforms exist in distinct ratios in different compartments of the nervous system and that splicing of exon 6 is governed by multiple branch points, exonic cis elements and additional trans factors. Recent results show that tau exon 6 is specifically suppressed in the brains of people who suffer from myotonic dystrophy type 1. The understanding of how tau exon 6 splicing is regulated may give us insights into the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17144905     DOI: 10.1111/j.1471-4159.2006.04252.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition.

Authors:  James Y Garbern; Manuela Neumann; John Q Trojanowski; Virginia M-Y Lee; Gerald Feldman; Joy W Norris; Michael J Friez; Charles E Schwartz; Roger Stevenson; Anders A F Sima
Journal:  Brain       Date:  2010-04-15       Impact factor: 13.501

2.  Expression and silencing of the microtubule-associated protein Tau in breast cancer cells.

Authors:  Tatiana Spicakova; Maureen M O'Brien; George E Duran; Alejandro Sweet-Cordero; Branimir I Sikic
Journal:  Mol Cancer Ther       Date:  2010-11-09       Impact factor: 6.261

3.  Transposition of two amino acids changes a promiscuous RNA binding protein into a sequence-specific RNA binding protein.

Authors:  Stephen M Garrey; Danielle M Cass; Anica M Wandler; Mary S Scanlan; J Andrew Berglund
Journal:  RNA       Date:  2007-11-13       Impact factor: 4.942

4.  Expression cloning in Xenopus identifies RNA-binding proteins as regulators of embryogenesis and Rbmx as necessary for neural and muscle development.

Authors:  Darwin S Dichmann; Russell B Fletcher; Richard M Harland
Journal:  Dev Dyn       Date:  2008-07       Impact factor: 3.780

5.  Microtubule-associated protein tau in human prostate cancer cells: isoforms, phosphorylation, and interactions.

Authors:  Skye Souter; Gloria Lee
Journal:  J Cell Biochem       Date:  2009-10-15       Impact factor: 4.429

6.  Tau 6D and 6P isoforms inhibit polymerization of full-length tau in vitro.

Authors:  Nichole E Lapointe; Peleg M Horowitz; Angela L Guillozet-Bongaarts; Andres Silva; Athena Andreadis; Lester I Binder
Journal:  Biochemistry       Date:  2009-12-29       Impact factor: 3.162

Review 7.  Regulation of human MAPT gene expression.

Authors:  Marie-Laure Caillet-Boudin; Luc Buée; Nicolas Sergeant; Bruno Lefebvre
Journal:  Mol Neurodegener       Date:  2015-07-14       Impact factor: 14.195

8.  The RNA encoding the microtubule-associated protein tau has extensive structure that affects its biology.

Authors:  Jonathan L Chen; Walter N Moss; Adam Spencer; Peiyuan Zhang; Jessica L Childs-Disney; Matthew D Disney
Journal:  PLoS One       Date:  2019-07-10       Impact factor: 3.240

Review 9.  The role of tau in neurodegenerative diseases and its potential as a therapeutic target.

Authors:  Michael S Wolfe
Journal:  Scientifica (Cairo)       Date:  2012-12-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.